Ampio Pharmaceuticals Inc (PK) News - AMPE

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Current Report Filing (8-k)

l UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering PR Newswire GREENWOOD VILLAGE, Colo., April 21...

(25)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C...

- Securities Registration (section 12(b)) (8-A12B)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-A FOR...

Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market

Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market PR Newswire GREENWOOD VILLAGE, Colo., May 17, 2011 GREENWOOD...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ...

- Securities Registration Statement (S-1)

Table of Contents As filed with the Securities and Exchange Commission on April 19, 2011...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement

Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement PR Newswire GREENWOOD...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ampio Pharmaceuticals Inc (PK) (AMPE)

Professional-Grade Tools, for Individual Investors.

AMPE News

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Current Report Filing (8-k)

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering

(25)

- Securities Registration (section 12(b)) (8-A12B)

Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market

- Quarterly Report (10-Q)

- Securities Registration Statement (S-1)

- Current report filing (8-K)

Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement

- Current report filing (8-K)

- Current report filing (8-K)

AMPE Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ampio Pharmaceuticals Inc (PK) (AMPE) News

Ampio Pharmaceuticals Inc (PK) (AMPE)

Professional-Grade Tools, for Individual Investors.

AMPE News

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Current Report Filing (8-k)

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering

(25)

- Securities Registration (section 12(b)) (8-A12B)

Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market

- Quarterly Report (10-Q)

- Securities Registration Statement (S-1)

- Current report filing (8-K)

Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement

- Current report filing (8-K)

- Current report filing (8-K)

AMPE Discussion

Your Recent History